Autoimmune diseases – Sector.Africa

New controlled clinical study conducted by doctors in France shows that Hydroxychloroquine cures 100% of coronavirus patients within 6 days of treatment

March 23, 2020March 24, 2020 Sector.Africa AdministratorAutoimmune diseases, Chloroarenes, Chloroquine, Connective tissue diseases, Coronavirus, Hydroxychloroquine, Medical specialties, Medicine, Middle East respiratory syndrome-related coronavirus, Quinolines, RTT, Viruses0 comment

Earlier today, we published a story about a new study published by NIH which shows that Hydroxychloroquine has been found to be more effective and potent than chloroquine in vitro treatment of coronavirus. While the media is focused on the vaccine race and leaving the discussion of THERAPEUTICS almost completely neglected, a recent well-controlled clinical study conducted by Didier Raoult M.D/Ph.D, et. al in France showed that 100% of patients that received a combination of HCQ and Azithromycin tested negative and were virologically cured within 6 days of treatment. In…

Teva to send US millions of malaria pills with potential to help COVID-19 | The Times of Israel

March 22, 2020 Sector.Africa AdministratorAntimalarial medication, Autoimmune diseases, Chemical compounds, Chloroarenes, Chloroquine, Didier Raoult, Hydroxychloroquine, Medical specialties, Medicine, Quinolines, RTT, Systemic lupus erythematosus0 comment

Israeli generic drug giant Teva announced Friday that it will provide ten million doses of its anti-malarial drug hydroxychloroquine, which could potentially prove effective in fighting the coronavirus pandemic, to US hospitals free of charge. The company said six million doses will be delivered to US hospitals by March 31, and more than ten million in a month. “We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” Teva executive vice president Brendan O’Grady said. US President Donald Trump…